0.75 CME Credits. This webinar discusses ADHD and its varied presentations, co-occurring issues, and the importance of accurate assessment for effective treatment.

0.50 CME Credits. Dr. Collier explores diagnosis, overlapping symptoms, and treatments for delirium in older adults.

0.25 CME Credits. In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials. First, we dive into the recent charges brought by the US Department of Justice against executives at Done, a California-based telehealth company, for alleged healthcare fraud. Done is accused of prescribing over 40 million Adderall pills to patients without proper evaluation, raising concerns about the balance between increasing mental healthcare access and responsible prescribing practices.

0.25 CME Credits. Highlights from this month include Lumateperone, Lavender, treatment resistant smoking, and Clonidine patches and Tourettes. A new meta analysis published in Psychiatry Research sheds light on a critical question.

0.50 CME Credits. Learn how to address depression in older adults, identify the risk factors and triggers, distinguish depression from normal aging, and explore effective treatment options.

There are two variations of long-acting injectable buprenorphine on the market. But what differentiates them, who might benefit, and how well do they work? Find out in today’s podcast.

Lithium, pramipexole, bupropion, carbamazepine, valproate, and trazodone. Meds that require special skill to start: 

Meds that require special skill to start: Clozapine and lamotrigine.

Dr. Josh Feder explains how parents can help kids feel safe when hearing about school shootings.

Ziprasidone and quetiapine. One goes better fast, one slow. Also the mystery of ghost pills, and a research update on pramipexole.

For LGBTQIA+ older adults, that line is crossed more often than we think.

Sometimes it looks like concern.

Sometimes it’s framed as protection.

But the impact is the same: autonomy is eroded, piece by piece.

Your patients are already using these treatments.The question is—should we be recommending them?

We’re often told antipsychotics are a last resort for agitation in dementia. And that’s true—they are. But when you do reach that last resort, you need to know how to use it—and how to talk about it with families.

We ask about alcohol.

We ask about weed.

Sometimes we even ask about TikTok.

But porn?